drugset / Trial / NCT06912165
A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
Th purpose of the study is to evaluate the dose response of WD-890 in efficacy at Week 16 in participants with moderate-to-severe plaque psoriasis.
Timeline
- Start
- 2024-12-31
- Primary completion
- 2025-10-30
- Completion
- 2025-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WD-890 | Unknown | — | — |
Indications
No indication recorded.